A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)
Clinical trial NCT01632345 · COMPLETED
Trial details
- NCT number
- NCT01632345
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-12
- Primary completion
- 2014-12-03
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.